Michael V Knopp
Overview
Explore the profile of Michael V Knopp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
160
Citations
3096
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eck B, Gaj S, Lartey R, Li M, Kim J, Winalski C, et al.
Quant Imaging Med Surg
. 2024 Dec;
14(12):8099-8118.
PMID: 39698646
Background: Dixon-based magnetic resonance imaging (MRI) intramuscular proton density fat fraction (PDFF) is a potentially useful imaging biomarker of muscle quality. However, multi-vendor, multi-site reproducibility of intramuscular PDFF quantification, required...
2.
Chan J, Geyer S, Zemla T, Knopp M, Behr S, Pulsipher S, et al.
N Engl J Med
. 2024 Sep;
392(7):653-665.
PMID: 39282913
Background: Treatment options for patients with advanced neuroendocrine tumors are limited. The efficacy of cabozantinib in the treatment of previously treated, progressive extrapancreatic or pancreatic neuroendocrine tumors is unclear. Methods:...
3.
Ahmed M, Melaragno L, Nyirjesy S, von Windheim N, Fenberg R, Herster R, et al.
J Oral Maxillofac Surg
. 2023 Jun;
81(9):1176-1185.
PMID: 37315925
Background: 3D-printed patient-specific anatomical models are becoming an increasingly popular tool for planning reconstructive surgeries to treat oral cancer. Currently there is a lack of information regarding model accuracy, and...
4.
Shankar L, Schoder H, Sharon E, Wolchok J, Knopp M, Wahl R, et al.
Lancet Oncol
. 2023 Mar;
24(3):e133-e143.
PMID: 36858729
As the immuno-oncology field continues the rapid growth witnessed over the past decade, optimising patient outcomes requires an evolution in the current response-assessment guidelines for phase 2 and 3 immunotherapy...
5.
Torka P, Pederson L, Knopp M, Poon D, Zhang J, Kahl B, et al.
Cancer Med
. 2023 Feb;
12(7):8211-8217.
PMID: 36799072
Background: Quantitative methods of Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) interpretation, including the percent change in FDG uptake from baseline (ΔSUV), are under investigation in lymphoma to overcome challenges associated with...
6.
Doolittle L, Binzel K, Nolan K, Craig K, Rosas L, Bernier M, et al.
Am J Respir Cell Mol Biol
. 2022 Apr;
66(6):682-693.
PMID: 35442170
Development of acute respiratory distress syndrome (ARDS) in influenza A virus (IAV)-infected mice is associated with inhibition of ATII (alveolar type II) epithelial cell phosphatidylcholine synthesis, and administration of the...
7.
Menendez M, Moore R, Abdel-Rasoul M, Wright C, Fernandez S, Jackson R, et al.
Front Med (Lausanne)
. 2022 Jan;
8:725118.
PMID: 35096851
The aim of the study was to assess the quality and reproducibility of reducing the injected [F] sodium fluoride ([F]NaF) dose while maintaining diagnostic imaging quality in bone imaging in...
8.
DiBartola A, Rogers A, Kurzweil P, Knopp M, Flanigan D
Arthrosc Sports Med Rehabil
. 2022 Jan;
3(6):e1755-e1760.
PMID: 34977630
Purpose: To assess the healing of horizontal cleavage tears of the meniscus 1 year after surgical repair and to determine what modality is best to determine healing. Methods: Patients were...
9.
Grossmann K, Othus M, Patel S, Tarhini A, Sondak V, Knopp M, et al.
Cancer Discov
. 2021 Nov;
12(3):644-653.
PMID: 34764195
Significance: Adjuvant PD-1 blockade therapy decreases the rates of recurrence, but not survival, in patients with surgically resectable melanoma, substituting the prior standard-of-care immunotherapies for this cancer. See related commentary...
10.
Hensing T, Wang X, Stinchcombe T, Gao J, Knopp M, Watson M, et al.
JTO Clin Res Rep
. 2021 Sep;
2(8):100208.
PMID: 34590049
Introduction: The sequence of chemotherapy and pembrolizumab may affect antitumor immune response and efficacy of immunotherapy. Methods: This multicenter, randomized, phase 2 trial was designed to evaluate the efficacy of...